We performed profiling of Ubiquitin modifications in human skin which we compared to clinically relevant patient samples that model dysregulated ubiquitination, CYLD cutaneous syndrome (CCS) tumours. We utilised protein peptide di-glycine immuno-purification to enrich for ubiquitinated substrates, f...
ORGANISM(S): Homo sapiens (Human)